Results 131 to 140 of about 106,315 (216)

Outlook Magazine, Summer 2016 [PDF]

, 2016
https://digitalcommons.wustl.edu/outlook/1198/thumbnail ...

core   +1 more source

Assessing XEN microstent’s one-year efficacy: independent of site variability [PDF]

International Journal of Ophthalmology
AIM: To evaluate the short-term efficacy of XEN45 Gel Stent (XEN) implantation for primary open angle glaucoma (POAG) and pseudoexfoliation (PEX) glaucoma across two university eye clinics, aiming to assess the impact of varying center-specific protocols
Caroline Bormann, Catharina Busch, Matus Rehak, Christian Thomas Scharenberg, Focke Ziemssen, Jan Darius Unterlauft   +5 more
doaj   +1 more source

Early diagnostics and interventional glaucoma

Therapeutic Advances in Ophthalmology
The glaucoma treatment paradigm is starting to change from a more reactive approach that relies on topical medications to a more proactive approach that leverages procedural interventions. This evolution toward interventional glaucoma has been enabled by
Ticiana De Francesco, Jason Bacharach, Oluwatosin Smith, Manjool Shah   +3 more
doaj   +1 more source

Surgical Outcomes of Gonioscopy-Assisted Transluminal Trabeculotomy (GATT) in Primary and Secondary Open- and Closed-Angle Glaucoma

Diagnostics
Background: Gonioscopy-assisted transluminal trabeculotomy (GATT) is a minimally invasive, ab interno conjunctival-sparing glaucoma surgery aimed at the trabecular meshwork and the inner wall of Schlemm’s canal. The goal of this study is to report on the
Liron Naftali Ben Haim, Veronika Yehezkeli, Assaf Kratz, Nimrod Dar, Tal Sharon, Gal Harel, Zvia Burganski-Eliash, Avner Belkin   +7 more
doaj   +1 more source

Visual rehabilitation in subconjunctival MIGS versus trabeculectomy and tube shunt surgery

AJO International
Background: To compare recovery of baseline visual acuity and persistent visual loss at 12-months in standalone subconjunctival minimally invasive glaucoma surgery (MIGS) vs trabeculectomy and tube shunt surgery in manifest and suspect glaucoma.
Jeremy C.K. Tan, Yohei Hashimoto, Hamish Dunn, David Wechsler, Shweta Kaushik, Louis Arnould, Andrew White, Mitchell Lawlor   +7 more
doaj   +1 more source

Current situation of minimally invasive glaucoma surgery in Brazil [PDF]

Revista Brasileira de Oftalmologia, 2022
Marcone Reis Luiz Júnior, Fábio Nishimura Kanadani   +1 more
doaj   +1 more source

MIGS, Cataract Surgery, or Both? An Analysis of Clinical Trial Data to Compare Efficacy and Outcomes on Glaucoma Patients

Journal of Clinical & Translational Ophthalmology
Background: Glaucoma is the leading cause of irreversible blindness around the world and is characterized as a group of irreversible optic neuropathies with multiple risk factors such as age, race/ethnicity, sex, and intraocular pressure (IOP), amongst ...
Jeremy Appelbaum, Abdullah Virk, Deepkumar Patel, Karen Allison   +3 more
doaj   +1 more source

Focusing on surgical and laser advances in glaucoma management [PDF]

, 2020
Introduction: Lowering the IOP remains the mainstay treatment to stop the progression of glaucoma. Different modalities can be used to achieve this including IOP lowering medications, laser, and surgeries.
Almonte, M, Cordeiro, F, Crawley, L, Mohamed, NG, Susanna, FN, Yap, TE   +5 more
core  

Endoscopic Laser Cyclodestruction: Clinical Aspects

Oftalʹmologiâ
Glaucoma is one of the main causes of irreversible vision loss worldwide, its prevalence is increasing with age, reaching 10 % in individuals over 90 years old.
A. N. Kulikov, V. Yu. Skvortsov, D. V. Tulin   +2 more
doaj   +1 more source

Washington University Record, October 22, 2009 [PDF]

, 2009
https://digitalcommons.wustl.edu/record/2191/thumbnail ...

core   +1 more source